Hypera S.A.

BOVESPA:HYPE3 Rapporto sulle azioni

Cap. di mercato: R$17.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Hypera Performance dei guadagni passati

Il passato criteri di controllo 2/6

Hypera ha registrato una crescita degli utili a un tasso medio annuo di 8.9%, mentre il settore Pharmaceuticals ha registrato utili in diminuzione a un tasso medio annuo di 2.8%. I ricavi sono stati in crescita a un tasso medio annuo di 20.6%. Il ritorno sul capitale proprio di Hypera è 14.1% e ha margini netti di 21.2%.

Informazioni chiave

8.9%

Tasso di crescita degli utili

8.8%

Tasso di crescita dell'EPS

Pharmaceuticals Crescita del settore12.4%
Tasso di crescita dei ricavi20.6%
Rendimento del capitale proprio14.1%
Margine netto21.2%
Prossimo aggiornamento sui guadagni06 Nov 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Jul 13
We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

Jun 20
Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 16
Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Is Hypera (BVMF:HYPE3) A Risky Investment?

Feb 21
Is Hypera (BVMF:HYPE3) A Risky Investment?

Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Jan 09
Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

Dec 22
Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Nov 02
Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Aug 27
Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Is Hypera (BVMF:HYPE3) A Risky Investment?

Jul 21
Is Hypera (BVMF:HYPE3) A Risky Investment?

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Apr 15
We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

Feb 19
With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

Jan 03
We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

Oct 11
Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 31
Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Jul 19
Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Jun 28
Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Apr 14
Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Mar 25
I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Mar 04
Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Ripartizione dei ricavi e delle spese

Come Hypera guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

BOVESPA:HYPE3 Ricavi, spese e utili (BRL Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 248,0011,6932,5070
31 Mar 248,0431,7042,5110
31 Dec 237,9151,6492,5210
30 Sep 238,1891,7722,5310
30 Jun 238,0861,7412,4920
31 Mar 237,7511,6942,3750
31 Dec 227,5461,7052,2990
30 Sep 227,0511,6402,1210
30 Jun 226,6481,6362,0170
31 Mar 226,2601,6601,9550
31 Dec 215,9371,6181,8950
30 Sep 215,4461,5771,8720
30 Jun 214,9021,4621,7560
31 Mar 214,4451,3821,6260
31 Dec 204,0891,3221,5640
30 Sep 203,8831,2431,5380
30 Jun 203,8031,1651,6050
31 Mar 203,7261,1061,6350
31 Dec 193,2951,1891,6110
30 Sep 193,2941,2521,5580
30 Jun 193,2331,2251,5080
31 Mar 193,1801,1641,4690
31 Dec 183,7241,1351,4810
30 Sep 183,7891,2881,5080
30 Jun 183,7161,2511,4770
31 Mar 183,6131,2001,4300
31 Dec 173,5001,1111,4100
30 Sep 173,2918191,3970
30 Jun 173,2267951,3800
31 Mar 173,2167431,3940
31 Dec 163,2286471,3720
30 Sep 163,2025571,3600
30 Jun 163,1294321,3390
31 Mar 163,0463491,3230
31 Dec 152,9573451,3070
30 Sep 151,5892637740
30 Jun 152,0393269440
31 Mar 152,4473601,0950
31 Dec 142,7683381,2450
30 Sep 144,4984001,9130
30 Jun 144,4233571,8630
31 Mar 144,3592491,8510
31 Dec 134,2592591,8040
30 Sep 134,1673321,7270

Guadagni di qualità: HYPE3 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di HYPE3 (21.2%) sono inferiori rispetto allo scorso anno (21.5%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di HYPE3 sono cresciuti del 8.9% all'anno negli ultimi 5 anni.

Accelerare la crescita: HYPE3 ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: HYPE3 ha avuto una crescita negativa degli utili ( -2.7% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Pharmaceuticals ( 7% ).

Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 14.1% ) di HYPE3 è considerato basso.

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate

7D

1Y

7D

1Y

7D

1Y